Health Services Research & Development

The topics were, and I may trip on the words here, facing efficacy of vernakalant for cardioversion and atrial fibrillation; benefits and safety of [unintelligible 28:27] patients with heart failure, hypertension, and previous myocardial infarction; and the evidence on the use of metformin combined with a dipeptidyl peptidase-4 inhibitor for a ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.